More doctors are disclosing payments from drug companies
BMJ 2017; 357 doi: https://doi.org/10.1136/bmj.j3195 (Published 30 June 2017) Cite this as: BMJ 2017;357:j3195
- Nigel Hawkes
- London
Nearly two thirds of doctors and other healthcare professionals in the UK have chosen to disclose the payments made to them by drug companies in 2016, a rise of 10 percentage points from 2015.
But some of those doctors who receive the bigger payments have withheld their names, as they are entitled to do. The 65% who chose to disclose accounted for 60% of the total payments, excluding those for conducting trials.
The industry paid a total of £454.5m (€520m; $590m) to work with healthcare professionals and healthcare organisations in the UK in 2016, the latest data released on the Association of the British Pharmaceutical Industry’s disclosure website show (www.disclosureuk.org.uk …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £157 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.